Riskpilot← Back to searchSign inGet full accessHOLMED AS
ASActiveOrg 911858436Holbergs Gate 6, 3717 SkienGeneral medical practice activities · NACE 8621Est. 20135 employees
Revenue 2024
NOK 5,3M
+16% vs 2023
EBITDA margin
-4.8%
+15% vs 2023
Equity ratio
-94.3%
Financial strength
Net profit 2024
NOK -295K
+16% vs 2023
| Revenue | NOK 5,3M | +16% |
| EBITDA | NOK -251K | +15% |
| Net profit | NOK -295K | +16% |
| Total assets | NOK 520K | +59% |
| Equity | NOK -491K | -151% |
| Employees | 5 | — |
Legal name
HOLMED AS
Org number
911858436
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. april 2013
Share capital
NOK 40 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Julie aas alstedt
Company purpose
Drifte et legekontor og tilby helsetjenester samt alt naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Holbergs Gate 6, 3717 Skien
Phone
+4735587090
Email
info@holmedgroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 944 | 3 508 | 4 417 | 4 546 | 5 283 |
| Staff expenses | −1 824 | −2 109 | −2 233 | −2 161 | −2 311 |
| EBITDA | −50 | 63 | 132 | −295 | −251 |
| Depreciation & amort. | −81 | −47 | −52 | −56 | −42 |
| EBIT | −131 | 16 | 80 | −351 | −293 |
| Net financials | −1 | −2 | −1 | −1 | −1 |
| Profit before tax | −132 | 15 | 80 | −352 | −295 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −132 | 15 | 80 | −352 | −295 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 205 | 870 | 1 009 | 328 | 520 |
| Equity | 452 | 467 | 156 | −196 | −491 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 753 | 404 | 853 | 524 | 1 011 |
| Total debt | 753 | 404 | 853 | 524 | 1 011 |
EBITDA margin
-4.8%
This company
15.8%
Market median
-130% vs market
20202024
Equity ratio
-94.3%
This company
38.2%
Market median
-347% vs market
20202024
Return on equity
-29478300.0%
This company
18.4%
Market median
-160208252% vs market
20202024
Net profit margin
-5.6%
This company
8.1%
Market median
-169% vs market
20202024
Asset turnover
10.15×
This company
1.12×
Market median
+806% vs market
20202024
Debt / equity
2.06×
This company
0.62×
Market median
-232% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LK Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
PO Chief Executive Officer | Chief Executive Officer | 2013 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2017 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HOLMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Ola Hogner Jahr | Chief Executive Officer | 0 companies |
| Lars Kølving Jensen | Chief Executive Officer | 0 companies |
| Knut Christian Johnsen | Board of Directors | 0 companies |
| Frikk Øverland Bergsli | Chairman | 0 companies |
| Julie Aas Alstedt | Board of Directors | 0 companies |